PBMs play role in personalizing medications for children
Pharmacy benefits managers are paying attention to medications that specifically target children
By Mari Edlin
Pharmacy benefits managers (PBMs) are paying attention to medications that specifically target children. Prime Therapeutics, a PBM in Eagan, Minnesota, considers all age groups when its pharmacy and therapeutics committee reviews drugs for formulary. For example, ethosuximide, a drug for seizures that has pediatric safety and effectiveness data, is included on formulary specifically for the pediatric population.
“Prime evaluates all drugs for an opportunity to improve the quality and safety of their use regardless of the age group for which they will be used,” says David Lassen, PharmD, chief clinical officer. “We follow scientific treatment guidelines and published clinical evidence to establish utilization management programs.”.
Similar to Prime, Express Scripts, a PBM based in St. Louis, builds its national formularies to serve large patient populations of all ages. “We have a pediatrician on the P&T Committee who helps assess new and existing medications and ensures that the needs of pediatrics and pediatricians are being met,” says Monique Parr, MD, director of clinical therapeutics.
“Pediatric dosing is incorporated into concurrent drug utilization programs used by Express Scripts,” she says. “We follow the drug labels and guidelines established by the FDA for pediatric dosing of drugs. In addition, safety programs such as RationalMed incorporate pediatric guidelines and age-based considerations.”
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
